Effectiveness and toxicity of lenvatinib in refractory thyroid cancer: Dutch real-life data

201955 citationsJournal Articlebronze Open Access

Authors

Mehtap Derya Aydemirli · Leiden University Medical Center

Ellen Kapiteijn · Leiden University Medical Center

Kaylee R M Ferrier · Radboud University Medical Center

P.B. Ottevanger · Radboud University Nijmegen

Thera P. Links · University Medical Center Groningen

Anouk N.A. van der Horst‐Schrivers · University Medical Center Groningen

K.E. Broekman

Abstract

PFS in our non-trial population was significantly shorter than in the SELECT trial population. In the interpretation of results, differences in the real-life population and the SELECT study population regarding patient characteristics should be taken into account.

Topics & Keywords

Thyroid Cancer Diagnosis and Treatment Thyroid and Parathyroid Surgery

Publication Details

Published in: European Journal of Endocrinology

Volume 182, Issue 2, pp. 131-138

DOI: 10.1530/eje-19-0763

Field-Weighted Citation Impact: 5.42

Command Palette

Effectiveness and toxicity of lenvatinib in refractory thyroid cancer: Dutch real-life data

Authors

Abstract

Topics & Keywords

Publication Details